Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
 
Sponsors and Collaborators

Peregrine Pharmaceuticals
 
Contact
Thomas Sklenar
714.508.6059
[email protected]
 
Principal Investigators
Thomas Sklenar
Peregrine Pharmaceuticals
 
ClinicalTrials.gov Identifier
NCT01272791